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The in vitro potency of neopterin (NP) as an antloxidant and its in vivo activity to suppress alloxan.induced diabetes were investigated. The reduced 
form of neopterin, 5,6,7,8-tetrahydroneopterin (NPH-4), showed an e~trcmely high supcroxide anion radical scavenging activity in two assay 
s:,,stems, i,e, xanthine/xanthine oxidase- and macrophage/phorbol myristate acetate (PMA).rcaction systems. NPH-4 also inhibited the oxidation 
of linoleie acid about as effectively as uric acid. Furthermore, NPH-4 ~md NP effectively suppressed alloxan-induced mouse diabetes. Th~e results 
suggest hat pteridines play an important role as endogenous antioxidants, 
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1. INTRODUCTION 
Neopterin (NP) is an ~-amino-hydroxypteridine e- 
rivative, and a precursor of biopterin (BP), which is 
derived from guanosine triphosphate [1]. It is now gen- 
erally accepted that NP is released from monocytes/ 
macrophages, that interferon-7' (INF-y), one of the im- 
munomodulators produced by activated T cells, is the 
only inducer for NP secretion from macrophages [2,3], 
and that 1NF-~ augments the intracellular concentra- 
tion ofguanosine triphosphate aswell as the conversion 
of it to NP [4]. Several biological roles of pteridines have 
been reported so far. Kaufman [5] showed that 5,6,7,8- 
tetrahydro-biopterin serves as a col'actor for mammal- 
ian aromatic amino acid mono-oxygenases, which hy- 
droxylate phenylalanine, tyrosine, and tryptophan, and 
thus regulate the biosynthesis of neurotransmitters in- 
eluding dopamine, norepinephrine and serotonin. A 
tetrahydropteridine derivative is also reported to be a 
col'actor for the enzymic oxidation of glyccrly ethers to 
alchohals [6]. Even though the exact physiological func- 
tions of pteridines are still obscure~ it has been suggested 
that NP might act as an endogenous inhibitor of folate 
synthesis in view of the major role of INF-7 ~ in the 
induction of antibacterial, antiprotozoal, and antifan- 
gal states in parasitized cells [7]. 
More recently, there have been many reports of sic- 
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nificant elevation of urinary or serum pteridine levels in 
patients with various malignant disorders, as well as in 
patients with viral diseases such as acquired immunode- 
ficiency syndrome [8-11]. 
Active oxygen species uch as superoxide anion radi- 
cals are thought o be potent pathogenic factors in var- 
ious viral diseases [12,13], so that the pathogenesis may 
involve not direct viral cytotoxicity and/or reactivity of 
active oxygen species. That is, an excess amount of 
active oxygen species following overreaction of immu- 
nodefense response against the virus-infected organs, 
may participate in the mechanism of tissue injuries ob- 
served in various types of viral diseases. We suspected 
that pteridines might play an important role as en- 
dogenous cavengers for these active oxygen species. 
Therefore we have investigated the potency of pteri- 
dines as antioxidants in vitro and in vivo. 
2. MATERIALS AND METHODS 
2.1. Reagents 
2-Methyl.6.phenyl-3,7.dihydroimidazo(l.2-=)-pyrazin-3-one 
(CLA) was purchased from Tokyo Kasei Kogyo Co,, Ltd. Phorbol 
myristate acetate (PMA), bovine erythrocyte Cu, Zn-supcroxide is- 
mutase (SOD) (grade IVX xanthine and xanthine oxida~ (XOD) were 
From Sigma Chemicals Co,, Ltd (St. Louis, MO). D-Neopterin (N P) 
and biopterin (BP) were also from Sigma Chemicals Co.. Ltd. 5,6,7.8- 
Tetrahydroneopterin (NPH-4) was from .lunsei Chemicals Co,. Ltd. 
2,2. Isolation of splenic ells 
Splenic ells were prepared from spleen of male ddY mou~. Blood 
was withdrawn from the abdominal aorta, and the spleen was re- 
moved. Total splenic ells including T-cells, B-cells. and macrophagcs. 
etc., were prepared by teasing the spleen with a syringe in cold Hanks' 
balanced salt solution (H BSS). After filtration through sterilized nylon 
wool mesh and centrifugation at 400xg for I0 min, the cells wcr-a 
suspended in HBSS and adjusted toa cell concentration f ixl0 v cells 
per ml. 
Published by Elsevier Science Publishers B.V. 163 
100, 
50. 
H : NPH-4  
H ; I ~  
i 
10 "~ 10 o 
Volume 304, number 2,3 FEBS LETTERS June 1992 
_ i , t  I I i t  
10 = 10 = 
Concentration (pM) 
Fig. I i Inhibitory effect of pteridines on superoxide anion radicals released in xanthin¢/XOD-reuetion system, 
2.3. Assay of superoxide Padical.seat,enging activity h.v chemihm~h2es. 
ce~lce 
The scavenging activity of pteridines for superoxide anion radicals 
was assayed in terms of redaction of chemiluminescence induced by 
0_~- according to the method of Nakano et al It 4]. As O,--generating 
systems, xanthine/XOO- arid maerophage/PMA-reaetion systems 
were used in this experiment, The reaction mixture of the xanthin¢/ 
XOD system contains 50 pM xanthine, 1,5/aM CLA. 15 mUnits ot' 
XOD, and an appropriate concentration f pteridin¢ in 1 ml of 50 ram 
Tris-HCI buffer (pH 7,6). The reaction was started by addition of 
XOD, In the ease of the macrophagc/PMA system, the reaction mix- 
ture contains 1×106 splenic cells, 1,0 #M diehtylen¢ triamine- 
N,N,N,N',N'-pentaacctic acid, 1,5#M CLA and 0.4yg of PMA in 1 
ml of HBSS. The reaction was started by the addition of PMA. Lumi- 
nescence was continuously monitored for I0 mln with a Luminescence 
reader (Aloka BLR 102), 
2,4, Inhibitory effect of pterkllnes on oxidation of I/noteic acid 
The oxidation of linoleic acid was conducted by the method of 
Smith and Lawing (15), with a slight modification, Briefly, linoleic 
acid (0,65 lnmol) was dissolved in I ca] of 0.65 M NaOH and diluted 
to 100 rnl with 0,2 M borate buffer (pH 9,0). Four ml oflinoleie acid 
solution was added to a 50 ml glass vessel containing 11 rnl of 0.2 M 
borate buffer, 1 ral of 0,1 rnM copper sulfate, and 1 rnl of 4 mM 
pteridine to give a total volume of 20 ml, Uric acid was used asa 
positive control antioxidant in this assay. The reaction vessels were 
shielded from light with tin foil and incubated at 37°C !br 30 h. One 
ml of the reaction mixture was taken oat at each time interval, 0.5 m] 
of 35% triehloroaeetic a id was added to it, and the level of thiobar. 
iturie acid.positive materials was assayed as described as Uchiyama 
and Mihara [16]. 
2.5, Effect of pteridbtes on allo.x'an.ittduced diabetes 
Male tidy mice were purchased from Tokyo Experimental Animals 
Co,, Ltd,, Tokyo, Japan, Alloxan was freshly dissolved in physiolog- 
ical saline and intravenously injected at a dose of 75 rng/kg body 
weight via tail vein. The animals were killed 24 h after the injection, 
NPH-4, NPo and BP were intra-peritoneally injected into rniee 10 rain 
befor~ ailoxan treatment a a dose of 3 rag/kg body weight, SOD was 
also administered at a dose of 5 rag/kg body weight in the same 
manner. P-lood specimens were withdrawn from the abdominal ort;; 
under sodium pentobarbital anesthesia, Sera were obtained by centrif- 
ugation of blood at 2500 rpm for 10 rain and subjected to glucose 
assay, by using glucose C[II]-TEST WAKe (Wake Pure Chemical, 
Industries, Ltd., Osaka). 
3. RESULTS AND DISCUSSION 
The scavenging activity of NPH-4, NP, and BP for 
superoxide anion radical was determined by using two 
anion radical-generating systems, i.e. xanthine/XOD- 
and the splenic macrophage/PMA-reaction systems, As 
shown in Fig. 1, NPH-4 showed a significant scavenging 
activity for the superoxide anion radical in the xanthine/ 
XOD-reaetion system, The 50% inhibitory concentra- 
tion (IC~o) was about 0.3/~M. In contrast, only weak 
activity were seen i NP and BP which gave IC~0 values 
of 370 pM and over 1 raM, respectively. The activity 
was also assayed in another O,--generating system, i.e. 
the splenic macrophage/PMA-reaction system (Fig. 2). 
In this assay system, high activities were observed with 
all pteridines: the values of IC~o were 0.33, 1.1, a~.ad 3,0 
#M, respectively. The differences of IC~o of pteridines 
obtained from these assays uggest that NPH-4 directly 
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Fig, 2, Inhibitory effect of pteridines on superoxide anion radicals 
releascd in splenic macrophage/PMA-reaction system, 
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Fig, 3. Inhibitory effect of pteridines on oxidation of linoleic acid, 
reacts with superoxide anion radical released in the xan. 
thine/XOD and macrophage/PMA-reaction systems, 
whereas NP and BP act on macrophages to decrease the 
generation of O,-. These results are consistent with the 
speculation that pteridines such as NPH-4, NP and BP 
play important roles as endogenous SOD like sub- 
stance, scavenging for the superoxide anion radical, 
Stimulation, such as viral infection, activates macro- 
phages to produce active oxygen species for defense, but 
large amounts of active oxygen species can sometimes 
cause serious cell/tissue injury. Thus, it would not be 
surprising if macrophage produced SOD-like sub- 
stances to protect hemselves. 
From a different point of view, the potency of pterid- 
ines as free radical scavengers was also investigated in
the air auto-oxidation of linoleic acid, 
As shown in Fig. 3, linoleic acid was conspicuously 
oxidized from 10 h and the oxidation reached saturation 
at 30 h after the start of incubation, The presence of 
pteridines protected linoleic acid from the oxidation for 
30 h. In particular, NPH-4 protected linoleic acid as 
effectively as uric acid, a typical free radical scavenger. 
The other pteridines, i.e. NP and BP, also inhibited the 
oxidation to about half that of the control at 20 h after 
the start of incubation. 
Active oxygen species have been suggested to be in- 
volved in various processes such as inflammation, 
carcinogenesis, and ageing, as well as experimental l- 
loxan-induced diabetes. A variety of agents with direct 
or indirect reducing activity toward active oxygen spe- 
cies have been shown to protect against allo}~an-induced 
diabetes [17-19]. As shown above, NPH-4 has a novel 
scavenging potency against not only superoxide anion 
radicals but also active oxygen radicals. Thus, we exam- 
ined the protective '~ -  - ~t.~.a~.y of NPH-4 against a!!oxan- 
induced diabetes. As shown in Fig. 4. NPH-4 com- 
pletely blocked the elevation of blood glucose level, as 
we had expected. NP was also active, but BP was not 
0 
Hir~l;!  AIIm~as 1~11-4 l ip  OP .~OD 
Fig. 4. Effect of pteridines on the elevated blood glucose level induced 
by alloxan, "'Signilicantly di~¢r from aliox:tn.treated group (P<O.01). 
very effective under these experimental conditions. 
These data indicate that the antioxidant activity of 
pteridines i manifested in vivo. However, the protective 
potency of pteridines was not always in accordance with 
in vitro antioxidant or radical scavenging activilies. 
This observation indicates that lipophilic NP may 
easily enter the ceils through the cell membrane, follow- 
ing to reduce to NPH-4 in living cells. On the basis of 
these results, we suggest that pteridines may play impor- 
tant role as endogenous antioxidants and also be useful 
as therapeutic agents against diseases in which active 
oxygen species play as the potent pathogenic factors. 
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